Pande Atul Insider Trading Activity

Average Profitability
99.21%
Insider Buys Quantity
2
Insider Buys Sum
$163,800.00
Insider Sells Quantity
2
Insider Sells Sum
$711,852.50

Insider Activity of Pande Atul

According to the SEC Form 4 filings, Pande Atul, being in a position of

  1. director at Immunovant, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 12000 shares for $424,650,
    over all time since 2021-08-13, has bought 25000 shares for $163,800, and sold 32100 shares for $1.14M.

Biography of Pande Atul

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$424,6505100

Comparison of Insiders on Amount of Buys and Sells

2026-08-28SaleImmunovant, Inc.
IMVT
director
1,500
0.0008%
$43.27$64,905-18.98%
2026-07-24SaleImmunovant, Inc.
IMVT
director
1,500
0.0007%
$39.80$59,700-5.2%
2026-06-26SaleImmunovant, Inc.
IMVT
director
1,500
0.0007%
$38.01$57,015-0.6%
2026-06-15SaleImmunovant, Inc.
IMVT
director
1,500
0.0007%
$34.02$51,030+15.19%
2026-05-20SaleImmunovant, Inc.
IMVT
director
6,000
0.0036%
$32.00$192,000+5.88%
2024-12-02SaleImmunovant, Inc.
IMVT
director
7,750
0.0052%
$28.54$221,185-39.41%
2023-12-01SaleImmunovant, Inc.
IMVT
director
12,350
0.0084%
$39.73$490,668-25.41%
2022-09-30PurchaseImmunovant, Inc.
IMVT
director
15,000
0.0117%
$5.60$84,000+223.92%
2021-08-13PurchaseImmunovant, Inc.
IMVT
director
10,000
0.0093%
$7.98$79,800-25.51%
Total: 9
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.